Background: Chronic noncancer pain is pervasive throughout the general patient population, transcending all chronic disease states. Patients with end-stage renal disease (ESRD) present a complicated population for which medication management requires careful consideration of the pathogenesis of ESRD and intimate knowledge of pharmacology. The origin of pain must also guide treatment options.
View Article and Find Full Text PDFUrine drug monitoring is an important tool for substance misuse or abuse and adherence to a prescribed regimen.
View Article and Find Full Text PDF